Evidence map›Paper›PMID 38853066›Full record

ArticleAtherosclerosis2024

Diet quality, front-of-pack labeling, and lipoprotein particle profiles.

Danielle E Haslam, Samia Mora

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Atherosclerosis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Danielle E HaslamChanning Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Samia MoraCenter for Lipid Metabolomics, Divisions of Preventive Medicine and Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address: smora@bwh.harvard.edu.

Funding

Total plasma and IgG glycomes, statin therapy and ASCVD eventsR01HL117861 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MORA, SAMIA · 2013 to 2022
$3.8M
Targeting the Active Resolution of Inflammation for Cardiovascular Disease PreventionR01HL160799 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MORA, SAMIA · 2022 to 2025
$3.0M
Reducing Inflammation for the Prevention of CVD: A Focus on Eicosanoid PathwaysR01HL134811 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MORA, SAMIA · 2017 to 2020
$3.0M
Circulating plasma metabolites, diet, and risk of type 2 diabetesR01DK112940 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI HU, FRANK B, MORA, SAMIA · 2018 to 2021
$2.9M
Patient Centered Approaches to Preventing ASCVD EventsK24HL136852 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SAMIA MORA · 2018 to 2026
$1.1M
Proteomic and integrative omic profiles of sugar- and artificially sweetened beverage consumption and changes in type 2 diabetes risk factorsK01DK136968 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI Danielle Haslam · 2023 to 2026
$634k
NHLBI NIH HHS K24 HL136852NHLBI NIH HHS R01 HL117861NHLBI NIH HHS R01 HL134811NHLBI NIH HHS R01 HL160799NIDDK NIH HHS K01 DK136968NIDDK NIH HHS R01 DK112940
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Food LabelingLipoproteinsBiomarkersCardiovascular DiseasesDiet, HealthyFemaleHumansMaleBiomarkersLipoproteinsDiet qualityFront-of-pack nutrition labelingLipidsLipoprotein particle sizeNutri-score

Identifiers

PMID38853066
PMCPMC12331383

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.